These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25882598)

  • 1. Primary Tumor Resection in Patients With Metastatic Colorectal Cancer Is Associated With Reversal of Systemic Inflammation and Improved Survival.
    Turner N; Tran B; Tran PV; Sinnathamby M; Wong HL; Jones I; Croxford M; Desai J; Tie J; Field KM; Kosmider S; Bae S; Gibbs P
    Clin Colorectal Cancer; 2015 Sep; 14(3):185-91. PubMed ID: 25882598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis.
    Mitsuya K; Nakasu Y; Kurakane T; Hayashi N; Harada H; Nozaki K
    J Neurosurg; 2017 Aug; 127(2):433-437. PubMed ID: 27911233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-lymphocyte ratio is a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer.
    Tohme S; Sukato D; Chalhoub D; McDonald KA; Zajko A; Amesur N; Orons P; Marsh JW; Geller DA; Tsung A
    Ann Surg Oncol; 2015 May; 22(5):1701-7. PubMed ID: 25190128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
    Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
    Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer.
    Shin JS; Suh KW; Oh SY
    J Surg Oncol; 2015 Nov; 112(6):654-7. PubMed ID: 26437893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors.
    Maeda K; Shibutani M; Otani H; Nagahara H; Sugano K; Ikeya T; Amano R; Kimura K; Sakurai K; Kubo N; Muguruma K; Tanaka H; Inoue T; Hirakawa K
    Anticancer Res; 2013 Dec; 33(12):5567-73. PubMed ID: 24324099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel scoring system predicting survival benefits of palliative primary tumor resection for patients with unresectable metastatic colorectal cancer: A retrospective cohort study protocol.
    Cao G; Zhou W; Chen E; Wang F; Chen L; Chen M; Zhao W; Xu J; Zhang W; Zhang G; Huang X; Song Z
    Medicine (Baltimore); 2019 Sep; 98(37):e17178. PubMed ID: 31517873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer.
    Azab B; Mohammad F; Shah N; Vonfrolio S; Lu W; Kedia S; Bloom SW
    Cancer Biomark; 2014; 14(5):303-12. PubMed ID: 25171472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation.
    Zhang Y; Peng Z; Chen M; Liu F; Huang J; Xu L; Zhang Y; Chen M
    Int J Hyperthermia; 2012; 28(2):132-40. PubMed ID: 22335227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
    Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
    Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Change of Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Metastatic Colorectal Cancer].
    Muneoka K; Shirai Y; Sasaki M; Sakata J; Kanda J; Wakabayashi H; Wakai T
    Gan To Kagaku Ryoho; 2017 Apr; 44(4):313-317. PubMed ID: 28428512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the perioperative neutrophil-to-lymphocyte ratio on the long-term survival following an elective resection of colorectal carcinoma.
    Kubo T; Ono S; Ueno H; Shinto E; Yamamoto J; Hase K
    Int J Colorectal Dis; 2014 Sep; 29(9):1091-9. PubMed ID: 25048875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Nishiguchi Y; Hirakawa K
    Anticancer Res; 2013 Aug; 33(8):3291-4. PubMed ID: 23898094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor.
    Xie QK; Chen P; Hu WM; Sun P; He WZ; Jiang C; Kong PF; Liu SS; Chen HT; Yang YZ; Wang D; Yang L; Xia LP
    J Transl Med; 2018 Oct; 16(1):273. PubMed ID: 30286769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
    Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U
    Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact of the neutrophil-lymphocyte ratio on the survival of patients with stage IV gastric cancer.
    Tanaka H; Muguruma K; Toyokawa T; Kubo N; Ohira M; Hirakawa K
    Dig Surg; 2014; 31(4-5):327-33. PubMed ID: 25471697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
    Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
    Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies.
    Spolverato G; Maqsood H; Kim Y; Margonis G; Luo T; Ejaz A; Pawlik TM
    J Surg Oncol; 2015 Jun; 111(7):868-74. PubMed ID: 25865111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.